239 related articles for article (PubMed ID: 35939063)
1. Adverse outcome pathways and linkages to transcriptomic effects relevant to ionizing radiation injury.
Yu J; Tu W; Payne A; Rudyk C; Cuadros Sanchez S; Khilji S; Kumarathasan P; Subedi S; Haley B; Wong A; Anghel C; Wang Y; Chauhan V
Int J Radiat Biol; 2022; 98(12):1789-1801. PubMed ID: 35939063
[TBL] [Abstract][Full Text] [Related]
2. A case example of a radiation-relevant adverse outcome pathway to lung cancer.
Chauhan V; Sherman S; Said Z; Yauk CL; Stainforth R
Int J Radiat Biol; 2021; 97(1):68-84. PubMed ID: 31846388
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer.
Stainforth R; Schuemann J; McNamara AL; Wilkins RC; Chauhan V
Int J Radiat Biol; 2021; 97(1):85-101. PubMed ID: 32909875
[TBL] [Abstract][Full Text] [Related]
4. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation.
Chauhan V; Hamada N; Monceau V; Ebrahimian T; Adam N; Wilkins RC; Sebastian S; Patel ZS; Huff JL; Simonetto C; Iwasaki T; Kaiser JC; Salomaa S; Moertl S; Azimzadeh O
Int J Radiat Biol; 2021; 97(11):1516-1525. PubMed ID: 34402738
[TBL] [Abstract][Full Text] [Related]
5. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease.
Azimzadeh O; Moertl S; Ramadan R; Baselet B; Laiakis EC; Sebastian S; Beaton D; Hartikainen JM; Kaiser JC; Beheshti A; Salomaa S; Chauhan V; Hamada N
Int J Radiat Biol; 2022; 98(12):1722-1751. PubMed ID: 35976069
[TBL] [Abstract][Full Text] [Related]
6. Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model.
Jeong J; Song T; Chatterjee N; Choi I; Cha YK; Choi J
Nanotoxicology; 2018 Dec; 12(10):1182-1197. PubMed ID: 30663905
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for the adverse outcome pathway framework to support radiation protection?
Chauhan V; Said Z; Daka J; Sadi B; Bijlani D; Marchetti F; Beaton D; Gaw A; Li C; Burtt J; Leblanc J; Desrosiers M; Stuart M; Brossard M; Vuong NQ; Wilkins R; Qutob S; McNamee J; Wang Y; Yauk C
Int J Radiat Biol; 2019 Feb; 95(2):225-232. PubMed ID: 30373433
[TBL] [Abstract][Full Text] [Related]
8. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
[TBL] [Abstract][Full Text] [Related]
9. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
[TBL] [Abstract][Full Text] [Related]
10. An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly.
Jaylet T; Quintens R; Armant O; Audouze K
Front Cell Dev Biol; 2023; 11():1197204. PubMed ID: 37427375
[TBL] [Abstract][Full Text] [Related]
11. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
[TBL] [Abstract][Full Text] [Related]
12. A strategy towards the generation of testable adverse outcome pathways for nanomaterials.
Murugadoss S; Vinković Vrček I; Pem B; Jagiello K; Judzinska B; Sosnowska A; Martens M; Willighagen EL; Puzyn T; Dusinska M; Cimpan MR; Fessard V; Hoet PH
ALTEX; 2021; 38(4):580-594. PubMed ID: 34008034
[TBL] [Abstract][Full Text] [Related]
13. Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro.
Klose J; Li L; Pahl M; Bendt F; Hübenthal U; Jüngst C; Petzsch P; Schauss A; Köhrer K; Leung PC; Wang CC; Koch K; Tigges J; Fan X; Fritsche E
Cell Biol Toxicol; 2023 Feb; 39(1):319-343. PubMed ID: 35701726
[TBL] [Abstract][Full Text] [Related]
14. Quantification of an Adverse Outcome Pathway Network by Bayesian Regression and Bayesian Network Modeling.
Moe SJ; Wolf R; Xie L; Landis WG; Kotamäki N; Tollefsen KE
Integr Environ Assess Manag; 2021 Jan; 17(1):147-164. PubMed ID: 32965776
[TBL] [Abstract][Full Text] [Related]
15. International expert group collaboration for developing an adverse outcome pathway for radiation induced leukemia.
Klokov D; Applegate K; Badie C; Brede DA; Dekkers F; Karabulutoglu M; Le Y; Rutten EA; Lumniczky K; Gomolka M
Int J Radiat Biol; 2022; 98(12):1802-1815. PubMed ID: 36040845
[TBL] [Abstract][Full Text] [Related]
16. Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.
Sachana M; Rolaki A; Bal-Price A
Toxicol Appl Pharmacol; 2018 Sep; 354():153-175. PubMed ID: 29524501
[TBL] [Abstract][Full Text] [Related]
17. The integration of the adverse outcome pathway framework to radiation risk assessment.
Chauhan V; Stricklin D; Cool D
Int J Radiat Biol; 2021; 97(1):60-67. PubMed ID: 32397918
[TBL] [Abstract][Full Text] [Related]
18. Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example.
Kozbenko T; Adam N; Lai V; Sandhu S; Kuan J; Flores D; Appleby M; Parker H; Hocking R; Tsaioun K; Yauk C; Wilkins R; Chauhan V
Int J Radiat Biol; 2022; 98(12):1777-1788. PubMed ID: 35939057
[TBL] [Abstract][Full Text] [Related]
19. Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.
Helm JS; Rudel RA
Arch Toxicol; 2020 May; 94(5):1511-1549. PubMed ID: 32399610
[TBL] [Abstract][Full Text] [Related]
20. A high-level overview of the OECD AOP Development Programme.
Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
